Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global stem cell therapy market.
The Stem
Cell Therapy Market is expected to reach USD
161.8 million by 2022, growing at a CAGR of 11.0% during the forecast period.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48
Market Segmentation:-
On the basis of mode of therapy, the global stem cell
therapy market is divided into two major categories, namely, allogeneic stem
cell therapy and autologous stem cell therapy. The allogeneic stem cell therapy
segment is expected to command the largest share of 95.2% in the global stem
cell therapy market in 2017 growing at a CAGR of 11.2% during the forecast
period.
On the basis of therapeutic application, the global Stem
Cell Therapy Industry is segmented into musculoskeletal disorders, wounds and
injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and
other applications. The musculoskeletal disorders segment is expected to
command the largest share of 61.1% in the global stem cell therapy market in
2017. Furthermore, the CVS diseases segment is expected to grow at the highest
CAGR of 13.0% during the forecast period.
On the basis of cell source, the global Stem Cell Therapy
Industry is divided into adipose derived MSCs, bone marrow derived MSCs,
embryonic / cord blood SCs, and other cell sources. The adipose derived MSCs
segment was expected to account for the largest share of 59.1% in the global
stem cell therapy market in 2017.
Market Growth Drivers :-
1 Growing Awareness Related to the
Therapeutic Potency of Stem Cells in Effective Disease Management
2 Development of Advanced
Genome-Based Cell Analysis Techniques
3 Increasing Public-Private
Investments for the Development of Stem Cell Therapies
4 Development in Infrastructure
Related to Stem Cell Banking and Processing
Regional
Analysis:-
North America is expected to be the largest regional
segment in the global stem cell therapy market in 2017, followed by
Asia-Pacific. In addition, the North American stem cell therapy market is
expected to be the fastest growing region during the forecast period, growing
at a CAGR of 11.5%.
Speak
To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=48
Key
Market Players:-
As of 2016, Osiris Therapeutics, Inc. (U.S.), MEDIPOST
Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co.,
Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR
Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc.
(U.S.), and AlloSource (U.S.) were some of the key players operating in the
global stem cell therapy market.
No comments:
Post a Comment